NeoVas Bioresorbable Coronary Scaffold First-in-Man Study

NCT02195414 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: NeoVas BCS

Sponsor

Lepu Medical Technology (Beijing) Co., Ltd.